183 related articles for article (PubMed ID: 2021297)
1. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.
Schweizer E; Rickels K; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1991 May; 48(5):448-52. PubMed ID: 2021297
[TBL] [Abstract][Full Text] [Related]
2. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
Rickels K; Schweizer E; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
[TBL] [Abstract][Full Text] [Related]
3. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
4. Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.
Schweizer E; Rickels K; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1990 Oct; 47(10):908-15. PubMed ID: 2222130
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.
Denis C; Fatséas M; Lavie E; Auriacombe M
Cochrane Database Syst Rev; 2006 Jul; (3):CD005194. PubMed ID: 16856084
[TBL] [Abstract][Full Text] [Related]
6. [The prophylaxis of benzodiazepine withdrawal syndrome in the elderly: the effectiveness of carbamazepine. Double-blind study vs. placebo].
Di Costanzo E; Rovea A
Minerva Psichiatr; 1992; 33(4):301-4. PubMed ID: 1297907
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Klein E; Colin V; Stolk J; Lenox RH
Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
[TBL] [Abstract][Full Text] [Related]
8. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Rickels K; Freeman EW
J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
[TBL] [Abstract][Full Text] [Related]
9. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
10. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome.
Schweizer E; Case WG; Garcia-Espana F; Greenblatt DJ; Rickels K
Psychopharmacology (Berl); 1995 Feb; 117(4):424-9. PubMed ID: 7604143
[TBL] [Abstract][Full Text] [Related]
11. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
McGregor C; Machin A; White JM
Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
[TBL] [Abstract][Full Text] [Related]
12. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
[TBL] [Abstract][Full Text] [Related]
13. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Noyes R; Garvey MJ; Cook B; Suelzer M
Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.
Voshaar RC; Gorgels WJ; Mol AJ; van Balkom AJ; Mulder J; van de Lisdonk EH; Breteler MH; Zitman FG
Can J Psychiatry; 2006 Jun; 51(7):445-52. PubMed ID: 16838826
[TBL] [Abstract][Full Text] [Related]
16. Long-term benzodiazepine users 3 years after participation in a discontinuation program.
Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R
Am J Psychiatry; 1991 Jun; 148(6):757-61. PubMed ID: 2035717
[TBL] [Abstract][Full Text] [Related]
17. Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group.
Zitman FG; Couvée JE
Br J Psychiatry; 2001 Apr; 178():317-24. PubMed ID: 11282810
[TBL] [Abstract][Full Text] [Related]
18. Electroacupuncture for tapering off long-term benzodiazepine use: A randomized controlled trial.
Yeung WF; Chung KF; Zhang ZJ; Zhang SP; Chan WC; Ng RM; Chan CL; Ho LM; Yu BY; Chau JC; Lau NC; Lao LX
J Psychiatr Res; 2019 Feb; 109():59-67. PubMed ID: 30504097
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin as adjunctive therapy in benzodiazepine discontinuation.
Caniff K; Telega E; Bostwick JR; Gardner KN
Am J Health Syst Pharm; 2018 Jan; 75(2):67-71. PubMed ID: 29317396
[TBL] [Abstract][Full Text] [Related]
20. [Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal].
Himmerich H; Nickel T; Dalal MA; Müller MB
Psychiatr Prax; 2007 Mar; 34(2):93-4. PubMed ID: 17124639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
